California State Teachers Retirement System (CalSTRS)
XERS icon

California State Teachers Retirement System (CalSTRS)’s Xeris Biopharma Holdings XERS Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
180,339
+29,168
+19% +$193K ﹤0.01% 1799
2025
Q4 		$1.19M Sell
151,171
-715
-0.5% -$5.63K ﹤0.01% 1712
2025
Q3 		$1.24M Buy
151,886
+141,725
+1,395% +$942K ﹤0.01% 1681
2025
Q2 		$47.5K Hold
10,161
– – ﹤0.01% 2312
2025
Q1 		$55.8K Hold
10,161
– – ﹤0.01% 2362
2024
Q4 		$34.4K Hold
10,161
– – ﹤0.01% 2454
2024
Q3 		$29K Hold
10,161
– – ﹤0.01% 2500
2024
Q2 		$22.9K Sell
10,161
-3,219
-24% -$6.49K ﹤0.01% 2552
2024
Q1 		$29.6K Sell
13,380
-8,522
-39% -$22K ﹤0.01% 2591
2023
Q4 		$51.5K Sell
21,902
-7,458
-25% -$13.8K ﹤0.01% 2593
2023
Q3 		$54.6K Sell
29,360
-14,903
-34% -$34.1K ﹤0.01% 2681
2023
Q2 		$116K Sell
44,263
-4,962
-10% -$12.6K ﹤0.01% 2619
2023
Q1 		$80.2K Sell
49,225
-3,630
-7% -$4.54K ﹤0.01% 2736
2022
Q4 		$70.3K Buy
52,855
+595
+1% +$840 ﹤0.01% 2855
2022
Q3 		$82K Sell
52,260
-4,357
-8% -$7.21K ﹤0.01% 2871
2022
Q2 		$87K Buy
+56,617
New +$119K ﹤0.01% 2919
2021
Q2 		– Sell
-69,556
Closed -$314K – 3257
2021
Q1 		$314K Hold
69,556
– – ﹤0.01% 2709
2020
Q4 		$342K Hold
69,556
– – ﹤0.01% 2599
2020
Q3 		$412K Buy
69,556
+15,411
+28% +$61.6K ﹤0.01% 2380
2020
Q2 		$144K Hold
54,145
– – ﹤0.01% 2859
2020
Q1 		$106K Buy
54,145
+13,647
+34% +$58.7K ﹤0.01% 2801
2019
Q4 		$286K Sell
40,498
-554
-1% -$4.57K ﹤0.01% 2637
2019
Q3 		$404K Hold
41,052
– – ﹤0.01% 2434
2019
Q2 		$470K Buy
41,052
+9,329
+29% +$97.9K ﹤0.01% 2399
2019
Q1 		$318K Buy
31,723
+21,243
+203% +$272K ﹤0.01% 2562
2018
Q4 		$178K Buy
10,480
+480
+5% +$9.63K ﹤0.01% 2801
2018
Q3 		$176K Buy
+10,000
New +$217K ﹤0.01% 2922

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s XERS Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Xeris Biopharma Holdings (XERS) stake by 19% in Q1 2026, buying an estimated $193K and bringing the position to 180,339 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

California State Teachers Retirement System (CalSTRS) first reported a position in XERS in Q3 2018 and has held it in 27 quarters since. The position peaked at $1.24M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 180,339 shares of Xeris Biopharma Holdings worth $1.05M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 29,168 Xeris Biopharma Holdings shares in Q1 2026, an estimated $193K.
  • Xeris Biopharma Holdings made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1799 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Xeris Biopharma Holdings in Q3 2018 and has held it in 27 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Xeris Biopharma Holdings position peaked at $1.24M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.